While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

“Lilly Canada stands behind Ebglyss as a first-line biological therapy for the treatment of atopic dermatitis and we remain committed ... Try Now>> See today’s best-performing stocks on TipRanks >> ...

Enhances Aclaris’ pipeline with complementary biologics portfolio -- Expands leadership team with addition of seasoned ...

In China, the number of patients with atopic dermatitis continues to ... and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases with ...

BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired ...

In the last few months, Pfizer has won approvals in the EU and US for JAK inhibitor Cibinqo (abrocitinib) as a treatment for moderate-to-severe atopic dermatitis in adults who cannot get relief ...

Approximately one third of parents of children with atopic dermatitis (AD ... do not currently recommend elimination diets as a treatment for AD, said Nadia Makkoukdji, MD, a pediatrician at ...

I was diagnosed with atopic dermatitis when I was 2 years old ... Finally, there was a moment when the eczema went dormant. It was the best 2 years of my life up to that point.

Learn about the benefits and risks of probiotic supplements and how to choose the best one for your health goals.